echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Sci Adv: Revealing the molecular mechanisms by which cancer cells are resistant to drugs

    Sci Adv: Revealing the molecular mechanisms by which cancer cells are resistant to drugs

    • Last Update: 2020-06-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    , June 9, 2020 /PRNewswire/ -- Scientists from the University of Bang
    or and others have been published in the international journalScience Advancesentitled "Mre11 exonuclease activity the schain-terminating nucleoside datingditabine from nascent-centered ingonsPicture Source: CC0 Public Domain
    Many cancer drugs kill cancer cells by inhibiting DNA replication, one of which is Gemcitabine, which can be used to treat pancreatic, bladder and lung cancer, and Gixithabin can simulate the basic elements of DNA - nucleoside deoxycytidine, which competes to be integrated into the DNA of cancer cells, which, once integrated, inhibits the replication and division of cancer cellsresearcher Hartsuiker said a special protein called Mre11 can remove gisitabin from DNA, which promotes the continued replication of cancer cells, which may explain a new type of gisitabin resistance mechanism in which cancer cells existresearchers explain that when Mre11 mutates frequently in cancer cells, researchers may be able to develop new cancer therapies or drugs, and now researchers have begun research on drug discovery, and they have identified a variety of compounds that inhibit Mre11 activity( origins:LBoeckemeier, RKraehenbuehl, AKeszthelyi, et al.
    Mre11 exonuclease activity y sy'n siens the chain-terminating nucleo o d'o dydd gemcitabine from the nascent strand ed DNA
    , Science Advances
    (2020) DOI: 10.1126/sciadv.aaz4126
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.